The Trump administration’s new tax law, the “One Big Beautiful Bill Act” (OBBB), has stirred significant debate...
Industries
Pharma Industries
The Department of Health and Human Services (HHS), under the direction of Secretary Robert F. Kennedy Jr.,...
The FDA has granted a significant expanded approval for fremanezumab-vfrm (Ajovy), a calcitonin gene-related peptide (CGRP) antagonist...
The FDA has officially expanded the approval of the intravenous (IV) formulation of tocilizumab-anoh (Avtozma; Celltrion Inc),...
European Commission Approves Vertex’s ALYFTREK® — A Next-Gen Breakthrough in Cystic Fibrosis Therapy
European Commission Approves Vertex’s ALYFTREK® — A Next-Gen Breakthrough in Cystic Fibrosis Therapy
Vertex Pharmaceuticals has announced that the European Commission has granted marketing authorization for its next-generation cystic fibrosis...
Pfizer has announced highly promising results from its Phase 3 BASIS clinical trial (NCT03938792), highlighting the efficacy...
AbbVie has released encouraging topline results from Study 2 of the Phase 3 UP-AA clinical program, assessing...
LENZ Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted approval for...
Novartis has disclosed the preliminary findings from its Phase III GCAptAIN study, assessing Cosentyx® (secukinumab) for the...
Global pharmaceutical leader Lupin Limited has unveiled the launch of Ipratropium Bromide Nasal Solution (Nasal Spray) in...
